Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorexys in premenopausal women with HSDD
NCT01857596Phase 2Completed
- Sponsor
- S1 Biopharma
- Start
- Apr 2013
- Primary completion
- Oct 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Lorexys in hypoactive sexual desire disorder (HSDD), sponsored by S1 Biopharma. Started Apr 2013; status: completed.
02
Drugs
Lorexys
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT01857596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857596.